Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,036 | 341 | 99.4% |
| Education | $29.99 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $836.79 | 59 | $0 (2024) |
| ABBVIE INC. | $558.40 | 47 | $0 (2024) |
| Novo Nordisk Inc | $548.34 | 37 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $480.27 | 31 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $397.06 | 22 | $0 (2024) |
| Lilly USA, LLC | $393.53 | 27 | $0 (2024) |
| Allergan, Inc. | $291.23 | 20 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $209.72 | 12 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $179.62 | 11 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $151.70 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $775.65 | 47 | PFIZER INC. ($176.95) |
| 2023 | $996.03 | 59 | ABBVIE INC. ($211.95) |
| 2022 | $719.35 | 48 | ABBVIE INC. ($135.92) |
| 2021 | $719.07 | 54 | AbbVie Inc. ($163.55) |
| 2020 | $645.17 | 45 | PFIZER INC. ($139.32) |
| 2019 | $524.32 | 37 | PFIZER INC. ($137.96) |
| 2018 | $386.29 | 29 | Allergan Inc. ($71.14) |
| 2017 | $300.56 | 23 | PFIZER INC. ($42.67) |
All Payment Transactions
342 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $28.29 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.05 | General |
| 11/08/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $1.69 | General |
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Respiratory | ||||||
| 11/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Obesity | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: PAIN | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.03 | General |
| Category: PAIN | ||||||
| 10/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: PAIN | ||||||
| 10/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $2.13 | General |
| Category: PAIN | ||||||
| 10/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Inflammation | ||||||
| 10/03/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $7.44 | General |
| 09/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $13.79 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Respiratory | ||||||
| 07/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: DIABETES | ||||||
| 07/11/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.20 | General |
| 07/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $1.14 | General |
| 06/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 537 | 866 | $125,932 | $48,034 |
| 2022 | 14 | 505 | 1,048 | $148,426 | $55,133 |
| 2021 | 19 | 606 | 1,117 | $152,236 | $62,296 |
| 2020 | 14 | 579 | 1,063 | $143,797 | $52,919 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 113 | 236 | $58,895 | $18,936 | 32.2% |
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 18 | 79 | $19,750 | $7,261 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 132 | $17,042 | $7,013 | 41.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 44 | 44 | $8,260 | $5,276 | 63.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 21 | $4,870 | $2,618 | 53.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 17 | $3,332 | $2,415 | 72.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 18 | 24 | $2,988 | $1,019 | 34.1% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 12 | 14 | $1,190 | $703.92 | 59.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 81 | 115 | $726.00 | $686.28 | 94.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 21 | $2,415 | $664.64 | 27.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 37 | 37 | $2,775 | $629.00 | 22.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 12 | $1,800 | $341.19 | 19.0% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 22 | 28 | $980.00 | $266.56 | 27.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 16 | 21 | $294.00 | $98.60 | 33.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 19 | 25 | $375.00 | $77.75 | 20.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 40 | $240.00 | $28.51 | 11.9% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 29 | 196 | $48,724 | $20,449 | 42.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 112 | 252 | $62,930 | $19,712 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 85 | 121 | $14,922 | $5,892 | 39.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 21 | $4,851 | $2,561 | 52.8% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 11 | 13 | $2,506 | $1,950 | 77.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 20 | 29 | $4,350 | $1,332 | 30.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 26 | 30 | $3,450 | $1,008 | 29.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 19 | 24 | $3,000 | $997.44 | 33.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 87 | 125 | $750.00 | $369.66 | 49.3% |
About Dr. Mark Mahoney, M.D
Dr. Mark Mahoney, M.D is a Family Medicine healthcare provider based in Mason City, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427028554.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Mahoney, M.D has received a total of $5,066 in payments from pharmaceutical and medical device companies, with $775.65 received in 2024. These payments were reported across 342 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,036).
As a Medicare-enrolled provider, Mahoney has provided services to 2,227 Medicare beneficiaries, totaling 4,094 services with total Medicare billing of $218,383. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Mason City, IA
- Active Since 01/23/2006
- Last Updated 03/30/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427028554
Products in Payments
- VRAYLAR (Drug) $376.81
- Ozempic (Drug) $339.11
- JARDIANCE (Drug) $327.82
- UBRELVY (Drug) $323.23
- ELIQUIS (Drug) $307.67
- NURTEC ODT (Drug) $282.81
- CHANTIX (Drug) $277.22
- FARXIGA (Drug) $255.02
- BREZTRI (Drug) $192.72
- EMGALITY (Drug) $176.20
- JANUVIA (Drug) $92.72
- TRULICITY (Drug) $90.46
- XIFAXAN (Drug) $88.33
- MOUNJARO (Drug) $84.84
- Trintellix (Drug) $80.06
- AJOVY (Drug) $79.67
- ENTRESTO (Drug) $77.32
- Aimovig (Biological) $77.09
- LEQVIO (Drug) $74.38
- STIOLTO RESPIMAT (Drug) $71.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Mason City
Spencer Turner
Family Medicine — Payments: $3,019
Aileen Prabhakaran, Md, MD
Family Medicine — Payments: $2,280
Patrick Courtney, Md, MD
Family Medicine — Payments: $1,032
Travis Johnson, Md, MD
Family Medicine — Payments: $922.06
David Ruen, Md, MD
Family Medicine — Payments: $750.04
Jessie Davis, Md, MD
Family Medicine — Payments: $613.45